tirzepatide phase 3 trial 80 weeks weight change shows 47% greater loss vs. Wegovy The Next Frontier of Weight

Adverse drug reactions (ADRs) are the fifth leading cause of death among all diseases and account for 5% to 10% of hospitalizations worldwide

For the best results, we encourage our patients to also maintain a healthy diet and regular exercise

Monitor your blood sugar levels regularly if you are on glucose-lowering medications to avoid complications and side effects

the Judicial Panel on Multidistrict Litigation added Saxenda to MDL 3094 in December 2024, expanding the scope to include this earlier-generation GLP-1 medication The consolidation of these medications into a single MDL proceedings streamlines the litigation process while allowing each plaintiff to maintain their individual claim for damages

* * * * * First annual wellness visit providing personalized prevention plan services * * * (xiii) At the discretion of the health professional and beneficiary, furnish a Physical Activity and Nutrition Risk Assessment that is standardized and evidence-based